Skip subpage navigation
The Department of Defense (DOD) and the Department of Veterans Affairs (VA) play distinct roles in dealing with chemical and biological (CB) exposures and are responsible for developing DOD deployment occupational and environmental health surveillance, risk assessment and risk management policies. DOD identifies and validates veteran’s exposure to CB agents and monitors deployment-related exposure incidents and trends. This ensures effective programs are in place to prevent occupational and environmental injuries or illnesses during deployment.
The Public Health Division collaborates with their DOD partners and the VA on long-term medical care and benefits for our service members. The division also provides the names of these individuals along with their exposure information to the VA. The VA then notifies individuals of their potential exposure, provides treatment, if necessary, for these individuals and adjudicates any claim for compensation.
These combined efforts are shaping the future of military medicine by supporting enhanced individual exposure assessment methods. The Public Health Division partners with federal research institutes on many projects to include:
- Development of exposure biomarkers
- Individual chemical dosimeters
- Individual Longitudinal Exposure Records
This page is designed to provide Service members, veterans, their families and the public with information on what happened during CB testing conducted years ago that potentially affected the health of those who served. It provides information on the tests conducted by DOD that possibly resulted in CB exposures only. For privacy reasons, it does not contain the names of the veterans exposed.
You also may be interested in...
Policy
Sep 17, 2009
.PDF |
1.33 MB
FHP&R Briefing to Military Service Organizations/Veterans Service Organizations: Chemical/Biological Exposure Databases (Presentation Slides and Summary)
- Identification #: N/A
- Type: Guideline
Report
Dec 19, 2008
.PDF |
3.70 MB
Defense Health Board (DHB) conducted an external review of a U.S. Army Center for Health Promotion and Preventive Medicine (USACHPPM) occupational and environmental health assessment conducted in 2003 at the Qarmat Ali Water Treatment Plant (WTP) in Basra, Iraq to address a potential sodium dichromate exposure to United States military service members.
Presentation
Dec 15, 2008
.PDF |
752.63 KB
Military Occupational Environmental Health and Medical Surveillance Subcommittee Update presented to the Defense Health Board Dec. 15, 2008
Presentation
Nov 20, 2008
.PDF |
705.26 KB
Military Occupational Environmental Health and Medical Surveillance Subcommittee Update presented to the Defense Health Board Nov. 20, 2008
Policy
Nov 3, 2008
.PDF |
434.03 KB
The purpose of this memorandum is to formally document policy on the use of the approved deployed electronic health record system, the Theater Medical Information Program-Joint (TMIP-J).
- Identification #: 08-017
- Type: Memorandum
Report
Jun 26, 2008
.PDF |
1.56 MB
Defense Health Board: Health Risk Assessment Burn Pit Exposures Balad Air Base Iraq
Presentation
Apr 24, 2008
.PDF |
2.05 MB
Armed Forces Health Surveillance Center Update presented to the Defense Health Board April 23, 2008
Policy
Feb 1, 2008
.PDF |
513.46 KB
Government Accountability Office (GAO) Report: GAO-08-366, “DoD and VA Need to Improve Efforts to Identify and Notify Individuals Potentially Exposed during Chemical and Biological Tests”
- Identification #: GAO-08-366
- Type: Guideline
Policy
Dec 18, 2007
.PDF |
147.91 KB
Policy on Analysis of Metal Fragments Removed from Department of Defense Personnel
- Identification #: 07-029
- Type: Memorandum
Presentation
May 23, 2007
.PDF |
3.38 MB
Global Emerging Infections Surveillance and Reporting System Update to the Defense Health Board May 23, 2007
Fact Sheet
May 4, 2005
.PDF |
160.05 KB
The Medical Countermeasures (MCM) Directorate assists in protecting U.S. forces that are globally engaged and at potentially increased risk to being exposed to naturally occurring substances or encountering manufactured chemical, biological, radiological or nuclear (CBRN) agents that adversaries may seek to use against them.
Policy
Dec 22, 2004
.PDF |
164.12 KB
Coordination of Policy to Establish a Joint Theater Trauma Registry
- Identification #: 04-031
- Type: Memorandum
Policy
May 1, 2004
Government Accountability Office (GAO) Report: GA)-04-410, “DoD Needs to Continue to Collect and Provide Information on Tests and on Potentially Exposed Personnel”.
- Identification #: GA-04-410
- Type: Guideline
Policy
Nov 6, 2003
.PDF |
83.85 KB
Medical Surveillance Information Management Strategy for Force Health Protection
- Identification #: 03-022
- Type: Memorandum
Policy
Oct 10, 2002
.PDF |
14.68 KB
Senate Armed Services Committee, Subcommittee on Personnel, Prepare Statement of Dr. William Winkenwerder, Jr., Assistant Secretary of Defense for Health Affairs, on Shipboard Hazard and Defense
- Identification #: N/A
- Type: Memorandum
You are leaving Health.mil
The appearance of hyperlinks does not constitute endorsement by the Department of Defense of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.
You are leaving Health.mil
View the external links disclaimer.
Last Updated: October 04, 2023